Does SIMVASTATIN Cause Disease recurrence? 104 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Disease recurrence have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.4% of all adverse event reports for SIMVASTATIN.
104
Reports of Disease recurrence with SIMVASTATIN
0.4%
of all SIMVASTATIN reports
44
Deaths
55
Hospitalizations
How Dangerous Is Disease recurrence From SIMVASTATIN?
Of the 104 reports, 44 (42.3%) resulted in death, 55 (52.9%) required hospitalization.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 104 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which SIMVASTATIN Alternatives Have Lower Disease recurrence Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS